In 2007, the FDA requested that manufacturers of all antidepressants, including Paxil and Prozac, update the existing black box warning on the drug???s label to include warnings about the increased risks of suicidal thoughts and tendencies in young adults ages 18 to 24 during the first one to two months of treatment.